Symvivo Competitors and Similar CompaniesClear all
Symvivo's competitors and similar companies include Morphogenesis and Neogene Therapeutics.
 Neogene Therapeutics Neogene Therapeutics is a pre-clinical stage biotechnology company that develops a new class of personalized T cell therapies to treat cancer. | |||
Founding Date | Founding Date 2013 | Founding Date 1995 | Founding Date 2018 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Burnaby, CA HQ | Locations Tampa, US HQ | Locations New York, US HQ Amsterdam, NL |
Employees | Employees 2 | Employees 19 | Employees 191 |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 16m (about 8 years ago) | Latest funding round $ 110m (almost 6 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 16m | Total funding raised $ 110m |
For sources of this data, please see the company profile
View Company Profiles
Morphogenesis
HQ
Tampa, US
Employees
19
Morphogenesis is a clinical stage company specializing in cell and gene therapies.
View companyNeogene Therapeutics
HQ
New York, US
Employees
191
Neogene Therapeutics is a pre-clinical stage biotechnology company that develops a new class of personalized T cell therapies to treat cancer.
View company